urea and regorafenib

urea has been researched along with regorafenib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barclay, W; Frise, R; Gravenstein, I; Herrmann, A; Imai-Matsushima, A; Karlas, A; Lesch, M; Luckner, M; Martin-Sancho, L; Meyer, M; Meyer, TF; Raftery, M; Schönrich, G; Sieben, C; Weege, F; Welke, RW	1

Other Studies

1 other study(ies) available for urea and regorafenib

Article	Year
RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals. PLoS pathogens, 2019, Volume: 15, Issue:3 Topics: A549 Cells; Active Transport, Cell Nucleus; Antiviral Agents; Host-Pathogen Interactions; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Orthomyxoviridae; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; RNA Interference; RNA Viruses; RNA, Small Interfering; Sorafenib; Urea; Virus Replication	2019

Article

Year

RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals.

PLoS pathogens, 2019, Volume: 15, Issue:3

Topics: A549 Cells; Active Transport, Cell Nucleus; Antiviral Agents; Host-Pathogen Interactions; Humans; Influenza A virus; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Orthomyxoviridae; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; RNA Interference; RNA Viruses; RNA, Small Interfering; Sorafenib; Urea; Virus Replication

2019